Redmile Group, LLC

Insider Reports History

Entity
Company
Location
One Letterman Drive, Building D, Suite D3 300, San Francisco, CA
Signature
By: /s/ Jeremy Green, Managing Member of Redmile Group, LLC
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Redmile Group, LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RayzeBio, Inc. 10%+ Owner Common Stock 1.86M $116M $62.50 Sep 19, 2023 Indirect
Shattuck Labs, Inc. Director, 10%+ Owner Common Stock 5.62M $59.1M $10.53 Mar 28, 2024 Indirect
FATE THERAPEUTICS INC Director, 10%+ Owner Common Stock 13.2M $57.6M $4.37 Dec 26, 2023 Indirect
IGM Biosciences, Inc. Director, 10%+ Owner Non-Voting Common Stock 7.2M $47.5M $6.60 Feb 28, 2024 Indirect
ADC Therapeutics SA 10%+ Owner Common Shares, par value CHF 0.08 per share 15.7M $44M $2.81 Jul 1, 2024 Indirect
Absci Corp Director Common Stock 8.26M $41.1M $4.98 Jun 12, 2024 Indirect
ADC Therapeutics SA 10%+ Owner Pre-Funded Warrants 8.16M $39.3M $4.81 May 8, 2024 Indirect
ADC Therapeutics SA 10%+ Owner Common Shares, par value CHF 0.08 per share 13M $36.5M $2.81 Jul 1, 2024 Direct
IGM Biosciences, Inc. Director, 10%+ Owner Common Stock 3.08M $35.6M $11.54 Sep 30, 2024 Indirect
Entrada Therapeutics, Inc. 10%+ Owner Common Stock 1.95M $31.3M $15.99 Nov 2, 2021 Indirect
Zymeworks Inc. 10%+ Owner Common Stock, par value $0.00001 per share 6.08M $30.6M $5.03 Oct 13, 2022 Indirect
ADC Therapeutics SA 10%+ Owner Pre-Funded Warrants 6.11M $29.4M $4.81 May 8, 2024 Direct
FATE THERAPEUTICS INC Director, 10%+ Owner Pre-Funded Warrants to Purchase Common Stock 3.89M $21.4M $5.50 Mar 21, 2024 Indirect
Verve Therapeutics, Inc. 10%+ Owner Common Stock 1.94M $19.4M $10.00 Jun 21, 2021 Indirect
Adagio Therapeutics, Inc. 10%+ Owner Common Stock 3.39M $13.4M $3.95 Aug 10, 2021 Indirect
ADC Therapeutics SA 10%+ Owner Cash-settled Swaps 108K $364K $3.38 Feb 7, 2024 Direct
FATE THERAPEUTICS INC Director, 10%+ Owner Stock Option (Right to Buy) 40K $109K $2.73 Jun 7, 2024 Indirect
ADC Therapeutics SA 10%+ Owner Cash-settled Swaps 11.2K $37.8K $3.38 Feb 2, 2024 Indirect
Augmedix, Inc. Director, 10%+ Owner Common Stock 0 $0 $2.35 Oct 2, 2024 Direct
Augmedix, Inc. Director, 10%+ Owner Common Stock 0 $0 $2.35 Oct 2, 2024 Indirect
Science 37 Holdings, Inc. Former 10% Owner and Director Common Stock 0 $0 $5.75 Mar 12, 2024 Indirect
MedAvail Holdings, Inc. Director, 10%+ Owner Series A Warrants to Purchase Common Stock 38.9M Jun 16, 2023 Direct
MedAvail Holdings, Inc. Director, 10%+ Owner Series A Warrants to Purchase Common Stock 38.9M Jun 16, 2023 Indirect
Shattuck Labs, Inc. Director, 10%+ Owner Pre-Funded Warrant to Purchase Common Stock 3.1M Dec 21, 2023 Indirect
Augmedix, Inc. Director, 10%+ Owner Breakeven Warrant 1.09M Nov 20, 2023 Direct
Augmedix, Inc. Director, 10%+ Owner Breakeven Warrant 1.09M Nov 20, 2023 Indirect
Absci Corp Director Stock Option (Right to Buy) 36.3K Jun 12, 2024 Indirect
IGM Biosciences, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 29.4K Mar 12, 2024 Indirect
Shattuck Labs, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 27.7K Jun 21, 2024 Indirect
Adagio Therapeutics, Inc. 10%+ Owner Series C Preferred Stock 0 Aug 10, 2021 Indirect
Augmedix, Inc. Director, 10%+ Owner Breakeven Warrants 0 Oct 2, 2024 Direct
Augmedix, Inc. Director, 10%+ Owner Breakeven Warrants 0 Oct 2, 2024 Indirect
Augmedix, Inc. Director, 10%+ Owner Pre-Funded Warrants to Purchase Common Stock 0 Oct 2, 2024 Direct
Augmedix, Inc. Director, 10%+ Owner Pre-Funded Warrants to Purchase Common Stock 0 Oct 2, 2024 Indirect
Entrada Therapeutics, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 Nov 2, 2021 Indirect
RayzeBio, Inc. 10%+ Owner Series B Preferred Stock 0 Sep 19, 2023 Indirect
RayzeBio, Inc. 10%+ Owner Series C Preferred Stock 0 Sep 19, 2023 Indirect
RayzeBio, Inc. 10%+ Owner Series D Preferred Stock 0 Sep 19, 2023 Indirect
Science 37 Holdings, Inc. Former 10% Owner and Director Earn-Out Right 0 Mar 12, 2024 Indirect
Science 37 Holdings, Inc. Former 10% Owner and Director Stock Options (Right to Buy) 0 Mar 12, 2024 Indirect
Verve Therapeutics, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 Jun 21, 2021 Indirect

Insider Reports Filed by Redmile Group, LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AUGX Augmedix, Inc. Oct 2, 2024 7 -$75.4M 4 Oct 4, 2024 Director, 10%+ Owner
IGMS IGM Biosciences, Inc. Sep 30, 2024 1 $0 4 Oct 2, 2024 Director, 10%+ Owner
ADCT ADC Therapeutics SA Jul 1, 2024 2 $2.25M 4 Jul 3, 2024 10%+ Owner
IGMS IGM Biosciences, Inc. Jun 28, 2024 1 $0 4 Jul 2, 2024 Director, 10%+ Owner
STTK Shattuck Labs, Inc. Jun 21, 2024 1 $0 4 Jun 21, 2024 Director, 10%+ Owner
AUGX Augmedix, Inc. Jun 14, 2024 1 $0 4 Jun 18, 2024 Director, 10%+ Owner
ABSI Absci Corp Jun 12, 2024 2 $0 4 Jun 14, 2024 Director
FATE FATE THERAPEUTICS INC Jun 7, 2024 1 $0 4 Jun 11, 2024 Director, 10%+ Owner
ADCT ADC Therapeutics SA May 8, 2024 2 $68.7M 4 May 10, 2024 10%+ Owner
STTK Shattuck Labs, Inc. Mar 28, 2024 1 $0 4 Apr 1, 2024 Director, 10%+ Owner
IGMS IGM Biosciences, Inc. Mar 28, 2024 2 $0 4 Apr 1, 2024 Director, 10%+ Owner
FATE FATE THERAPEUTICS INC Mar 21, 2024 1 $20M 4 Mar 25, 2024 Director, 10%+ Owner
AUGX Augmedix, Inc. Mar 15, 2024 1 $0 4 Mar 19, 2024 Director, 10%+ Owner
IGMS IGM Biosciences, Inc. Mar 12, 2024 1 $0 4 Mar 14, 2024 Director, 10%+ Owner
SNCE Science 37 Holdings, Inc. Mar 12, 2024 3 -$5.85M 4 Mar 13, 2024 Former 10% Owner and Director
ABSI Absci Corp Mar 1, 2024 1 $1M 4 Mar 5, 2024 Director
IGMS IGM Biosciences, Inc. Feb 28, 2024 2 $0 4 Mar 1, 2024 Director, 10%+ Owner
ADCT ADC Therapeutics SA Jan 3, 2024 22 -$167K 4 Feb 9, 2024 10%+ Owner
ADCT ADC Therapeutics SA Jan 2, 2024 0 $0 3 Feb 9, 2024 10%+ Owner
IGMS IGM Biosciences, Inc. Dec 29, 2023 1 $0 4 Jan 3, 2024 Director
FATE FATE THERAPEUTICS INC Dec 26, 2023 3 $166K 4 Dec 28, 2023 Director, 10%+ Owner
STTK Shattuck Labs, Inc. Dec 21, 2023 1 $0 4 Dec 26, 2023 Director, 10%+ Owner
AUGX Augmedix, Inc. Dec 15, 2023 1 $0 4 Dec 19, 2023 Director, 10%+ Owner
AUGX Augmedix, Inc. Nov 20, 2023 4 $6M 4 Nov 22, 2023 Director, 10%+ Owner
IGMS IGM Biosciences, Inc. Sep 29, 2023 1 $0 4 Oct 3, 2023 Director
RYZB RayzeBio, Inc. Sep 19, 2023 6 $0 4 Sep 21, 2023 10%+ Owner
RYZB RayzeBio, Inc. Sep 14, 2023 0 $0 3 Sep 14, 2023 10%+ Owner
AUGX Augmedix, Inc. Aug 31, 2023 1 $10K 4 Sep 5, 2023 Director, 10%+ Owner
AUGX Augmedix, Inc. Jul 13, 2023 1 $0 4 Jul 17, 2023 Director, 10%+ Owner
IGMS IGM Biosciences, Inc. Jun 29, 2023 5 $0 4 Jul 3, 2023 Director
IGMS IGM Biosciences, Inc. Jun 26, 2023 1 $22.5M 4 Jun 28, 2023 Director
MDVL MedAvail Holdings, Inc. Jun 16, 2023 2 $0 4 Jun 21, 2023 Director, 10%+ Owner
ABSI Absci Corp Jun 14, 2023 1 $0 4 Jun 16, 2023 Director
FATE FATE THERAPEUTICS INC Jun 6, 2023 1 $0 4 Jun 8, 2023 Director, 10%+ Owner
STTK Shattuck Labs, Inc. May 26, 2023 1 $0 4 May 31, 2023 Director, 10%+ Owner
SNCE Science 37 Holdings, Inc. May 11, 2023 1 $125K 4 May 15, 2023 Director, 10%+ Owner
AUGX Augmedix, Inc. May 2, 2023 3 -$15M 4 May 4, 2023 Director, 10%+ Owner
FATE FATE THERAPEUTICS INC Apr 20, 2023 2 $1.71M 4 Apr 21, 2023 Director, 10%+ Owner
AUGX Augmedix, Inc. Apr 19, 2023 2 $7M 4 Apr 21, 2023 Director, 10%+ Owner
FATE FATE THERAPEUTICS INC Apr 13, 2023 12 -$1.61M 4 Apr 17, 2023 Director, 10%+ Owner
IGMS IGM Biosciences, Inc. Apr 4, 2023 1 $0 4 Apr 6, 2023 Director, 10%+ Owner
IGMS IGM Biosciences, Inc. Mar 31, 2023 1 $0 4 Apr 4, 2023 Director, 10%+ Owner
MDVL MedAvail Holdings, Inc. Mar 9, 2023 2 $25M 4 Mar 13, 2023 Director, 10%+ Owner
IGMS IGM Biosciences, Inc. Dec 30, 2022 1 $0 4 Jan 4, 2023 Director, 10%+ Owner
ZYME Zymeworks Inc. Oct 13, 2022 1 $153K 4/A Oct 18, 2022 10%+ Owner
ZYME Zymeworks Inc. Oct 13, 2022 0 $0 3 Oct 17, 2022 10%+ Owner
ZYME Zymeworks Inc. Oct 13, 2022 0 $0 3 Oct 17, 2022 10%+ Owner
IGMS IGM Biosciences, Inc. Oct 3, 2022 6 $0 4 Oct 5, 2022 Director, 10%+ Owner
IGMS IGM Biosciences, Inc. Sep 30, 2022 1 $0 4 Oct 4, 2022 Director, 10%+ Owner
MDVL MedAvail Holdings, Inc. Jul 1, 2022 4 $18.1M 4 Jul 6, 2022 Director, 10%+ Owner
IGMS IGM Biosciences, Inc. Jun 30, 2022 1 $0 4 Jul 5, 2022 Director, 10%+ Owner
SNCE Science 37 Holdings, Inc. Jun 13, 2022 2 $0 4 Jun 15, 2022 Director, 10%+ Owner
FATE FATE THERAPEUTICS INC Jun 9, 2022 2 $0 4 Jun 13, 2022 Director, 10%+ Owner
STTK Shattuck Labs, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director, 10%+ Owner
ABSI Absci Corp Jun 8, 2022 1 $0 4 Jun 10, 2022 Director, 10%+ Owner
SNCE Science 37 Holdings, Inc. May 23, 2022 1 $125K 4 May 25, 2022 Director, 10%+ Owner
MDVL MedAvail Holdings, Inc. Apr 4, 2022 2 $15M 4 Apr 6, 2022 Director, 10%+ Owner
IGMS IGM Biosciences, Inc. Mar 31, 2022 2 $60M 4 Apr 4, 2022 Director, 10%+ Owner
IGMS IGM Biosciences, Inc. Mar 12, 2022 1 $0 4 Mar 15, 2022 Director, 10%+ Owner
IGMS IGM Biosciences, Inc. Dec 31, 2021 1 $0 4 Jan 4, 2022 Director, 10%+ Owner
TRDA Entrada Therapeutics, Inc. Nov 2, 2021 3 $20M 4 Nov 4, 2021 10%+ Owner
AUGX Augmedix, Inc. Oct 28, 2021 1 $6.5M 4/A Apr 21, 2023 Director, 10%+ Owner
TRDA Entrada Therapeutics, Inc. Oct 28, 2021 0 $0 3 Oct 28, 2021 10%+ Owner
SNCE Science 37 Holdings, Inc. Oct 7, 2021 1 $0 4 Oct 12, 2021 Director, 10%+ Owner
SNCE Science 37 Holdings, Inc. Oct 6, 2021 1 $0 4/A Oct 18, 2021 Director, 10%+ Owner
SNCE Science 37 Holdings, Inc. Oct 6, 2021 0 $0 3 Oct 8, 2021 Director, 10%+ Owner
IGMS IGM Biosciences, Inc. Sep 30, 2021 1 $0 4 Oct 4, 2021 Director, 10%+ Owner
IVVD Adagio Therapeutics, Inc. Aug 10, 2021 3 $25M 4 Aug 12, 2021 10%+ Owner
IVVD Adagio Therapeutics, Inc. Aug 5, 2021 0 $0 3 Aug 5, 2021 10%+ Owner
ABSI Absci Corp Jul 26, 2021 5 $5M 4 Jul 28, 2021 Director
ABSI Absci Corp Jul 21, 2021 0 $0 3 Jul 21, 2021 Director, 10%+ Owner
IGMS IGM Biosciences, Inc. Jun 30, 2021 1 $0 4 Jul 2, 2021 Director, 10%+ Owner
VERV Verve Therapeutics, Inc. Jun 21, 2021 3 $20M 4 Jun 23, 2021 10%+ Owner
STTK Shattuck Labs, Inc. Jun 19, 2021 1 $0 4 Jun 22, 2021 Director, 10%+ Owner
VERV Verve Therapeutics, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 10%+ Owner
FATE FATE THERAPEUTICS INC Jun 2, 2021 2 $0 4 Jun 4, 2021 Director, 10%+ Owner